Adalimumab Proves Effective for Children with Juvenile Rheumatoid Arthritis
Adalimumab, an injectable anti-TNF therapy that has FDA approval for treating rheumatoid arthritis in adults, has proven effective in children with juvenile rheumatoid// arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Washington, DC. The immunosuppressant adalimumab, currently used to treat adults with moderate...Abbott's Humira(r) (Adalimumab) Gets Approval by EU for Crohn's Disease Treatment
ABBOTT PARK, Ill., Abbott announced today that it has received marketing authorization from the European Commission for the use of HUMIRA(R) (adalimumab) as a treatment for severe Crohn's disease. HUMIRA is the first self-administered biologic for the treatment of Crohn's disease and offers an effective and convenient treatment option that can help enable patients to maintain control of their di...